Why the study?
Cardiac imaging findings of inflammatory heart disease after COVID-19 infection are more common than most conditions causing sudden death during exercise, necessitating guidance on adapting routine preparticipation cardiovascular screening.
This document provides recommendations on adapting preparticipation cardiovascular screening for young competitive athletes to detect COVID-19 cardiovascular complications.
Answers are grounded in this paper and cite their sources.
May prompt COVID-19 history review during athlete screening; hypothesis-generating for sudden death risk and protocol changes.
Preparticipation cardiovascular screening, designed to identify cardiovascular pathology responsible for sudden unexpected death, is recommended by all major professional medical organizations overseeing the clinical care of competitive athletes. Data from several large, prospective, cohort studies indicate that cardiac imaging findings consistent with inflammatory heart disease following COVID-19 infection are more common than most forms of heart disease associated with sudden death during exercise. This call-to-action document is intended to provide recommendations about how routine preparticipation cardiovascular screening for young competitive athletes - which has the capacity to detect both COVID-19 cardiovascular complications and pathology unrelated to infection - should be altered to account for recent scientific advances.
No takes yet. Share an insight, caveat, or question.
A 2022 study studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: